Magnetically Targeted Stem Cell Delivery for Regenerative Medicine
Source abstract
Abstract
Stem cells play a special role in the body as agents of self-renewal and auto-reparation for tissues and organs. Stem cell therapies represent a promising alternative strategy to regenerate damaged tissue when natural repairing and conventional pharmacological intervention fail to do so. A fundamental impediment for the evolution of stem cell therapies has been the difficulty of effectively targeting administered stem cells to the disease foci. Biocompatible magnetically responsive nanoparticles are being utilized for the targeted delivery of stem cells in order to enhance their retention in the desired treatment site. This noninvasive treatment-localization strategy has shown promising results and has the potential to mitigate the problem of poor long-term stem cell engraftment in a number of organ systems post-delivery. In addition, these same nanoparticles can be used to track and monitor the cells in vivo, using magnetic resonance imaging. In the present review we underline the principles of magnetic targeting for stem cell delivery, with a look at the logic behind magnetic nanoparticle systems, their manufacturing and design variants, and their applications in various pathological models.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Joint Department of Biomedical Engineering, UNC-Chapel Hill & NC State University, NC 27606, USA
Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA
Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
References (61)
Show source-provided references
1. Rudolph, K. (2015). Adult Stem Cells in Aging, Diseases, and Cancer, Karger AG.10.1159/isbn.978-3-318-02732-7 ↗
2. Stem Cell Information. National Institutes of Health, U.S. Department of Health and Human Services Website, Available online: http://stemcells.nih.gov/info/basics/pages/basics1.aspx.
3. Myocardial infarction and stem cells10.4103/0975-7406.80761 ↗
4. Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent10.1002/jbm.a.33133 ↗
5. Stem cell therapy for vascular regeneration: Adult, embryonic, and induced pluripotent stem cells10.1161/CIRCULATIONAHA.109.881441 ↗
6. Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles10.3727/096368911X627435 ↗
7. An effective strategy of magnetic stem cell delivery for spinal cord injury therapy10.1039/C4NR05791K ↗
8. Stem cell transplantation for neuroprotection in stroke10.3390/brainsci3010239 ↗
9. United Networks for Organs Sharing. Available online: http://www.unos.org.
10. Optimizing hematopoietic stem cell engraftment: A novel role for thrombopoietin10.1172/JCI0216376 ↗
11. Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction10.1016/j.biomaterials.2014.06.031 ↗
12. Guidance of stem cells to a target destination in vivo by magnetic nanoparticles in a magnetic field10.1021/am400249n ↗
13. Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo10.2217/nnm.12.109 ↗
14. In vivo trafficking and targeted delivery of magnetically labeled stem cells10.1089/104303404322959506 ↗
15. Magnetic nanoparticles: Synthesis, protection, functionalization, and application10.1002/anie.200602866 ↗
16. Magnetic tagging increases delivery of circulating progenitors in vascular injury10.1016/j.jcin.2009.05.014 ↗
17. In vivo tracking of stem cells for clinical trials in cardiovascular disease10.1161/01.CIR.0000149840.46523.FC ↗
18. What Is an MRI Scan? WebMD Boots Website. Available online: http://www.webmd.boots.com/a-to-z-guides/what-is-an-mri-scan?page=2.
19. Progatzky, F., Dallman, M.J., and Lo Celso, C. (2013). From seeing to believing: Labelling strategies for in vivo cell-tracking experiments. Interface Focus, 3.10.1098/rsfs.2013.0001 ↗
20. National institute of biomedical imaging and bioengineering: Poised for the future10.1148/radiol.2293031004 ↗
21. Tests and procedures. Positron Emission Tomography (PET) Scan. Mayo Clinic Website. Available online: http://www.mayoclinic.org/tests-procedures/pet-scan/basics/risks/prc-20014301.
22. What Is an Ultrasound? Benefits of Ultrasound. WebMD Boots Website. Available online: http://www.webmd.com/a-to-z-guides/what-is-an-ultrasound?page=2#2.
23. U.S. Food and Drug Administration Medical X-ray Imaging, Available online: http://www.fda.gov/Radiation-EmittingProducts/RadiationEmittingProductsandprocedures/medicalimaging/medicalx-rays/default.htm#risks.
24. Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine10.1155/2012/614094 ↗
25. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents10.1073/pnas.0708338105 ↗
26. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: Methods and techniques10.1097/01.TP.0000089237.39220.83 ↗
27. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging10.1038/nm.2666 ↗
28. Dextran-coated iron oxide nanoparticles: A versatile platform for targeted molecular imaging, molecular diagnostics, and therapy10.1021/ar200084x ↗
29. Cortajarena, A.L., Ortega, D., Ocampo, S.M., Gonzalez-García, A., Couleaud, P., Miranda, R., Belda-Iniesta, C., and Ayuso-Sacido, A. (2014). Engineering iron oxide nanoparticles for clinical settings. Nanobiomedicine, 1.10.5772/58841 ↗
30. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)10.3402/nano.v1i0.5358 ↗
31. Magnetic nanoparticles for MR imaging: Agents, techniques and cardiovascular applications10.1007/s00395-008-0710-7 ↗
32. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy10.1016/j.addr.2010.05.006 ↗
33. In vivo MRI cell tracking: Clinical studies
34. Magnetic iron oxide nanoparticles : Synthesis and surface coating techniques for biomedical applications
35. Size-controlled synthesis and characterization of Fe3O4 nanoparticles by chemical coprecipitation method
36. In vitro study of deep capture of paramagnetic particle for targeting therapeutics10.1016/j.jmmm.2009.04.041 ↗
37. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics10.1016/j.biomaterials.2009.11.062 ↗
38. The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation10.1016/j.biomaterials.2013.08.092 ↗
39. Surface modification of nanoparticles used in biomedical applications
40. National Institute of Diabetes and Digestive and Kidney Diseases: Hemochromatosis, Available online: http://www.niddk.nih.gov/health-information/health-topics/liver-disease/hemochromatosis/Pages/facts.
41. Huong, N.T., Giang, L.T.K., Binh, N.T., and Minh, L.Q. (2009). Surface modification of iron oxide nanoparticles and their conjuntion with water soluble polymers for biomedical application. J. Phys. Conf. Ser., 187.10.1088/1742-6596/187/1/012046 ↗
42. Usher, T.C., and Walls, S.H. (2004). Process of Making Carboxylated Dextran. (6,703,499 B1), U.S. Patent.
43. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking10.1016/j.biomaterials.2012.02.064 ↗
44. Nanocarriers’ entry into the cell: Relevance to drug delivery10.1007/s00018-009-0053-z ↗
45. Yi, G., Li, S., Wang, S., and Moore, R. (2014). Nanomedicine, Springer.
46. Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use10.5966/sctm.2013-0049 ↗
47. Huang, Z., Shen, Y., Sun, A., Huang, G., Zhu, H., Huang, B., Xu, J., Song, Y., Pei, N., and Ma, J. (2013). Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Stem Cell Res. Ther., 4.10.1186/scrt360 ↗
48. Clathrin10.1146/annurev.biochem.69.1.699 ↗
49. Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury
50. In vitro targeted magnetic delivery and tracking of superparamagnetic iron oxide particles labeled stem cells for articular cartilage defect repair10.1007/s11596-011-0253-2 ↗
51. Articular cartilage repair with magnetic mesenchymal stem cells10.1177/0363546513483270 ↗
52. Magnetic targeting of bone marrow stromal cells into spinal cord: Through cerebrospinal fluid10.1097/01.wnr.0000227993.07799.a2 ↗
53. Magnetically labeled neural progenitor cells, which are localized by magnetic force, promote axon growth in organotypic cocultures10.1097/BRS.0b013e318154c651 ↗
54. Cheng, K., Shen, D., Hensley, T.M., Middleton, R., Sun, B., Liu, W., De Couto, G., and Marbán, E. (2014). Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. Nat. Commun., 5.10.1038/ncomms5880 ↗
55. Construction and delivery of tissue-engineered human retinal pigment epithelial cell sheets, using magnetite nanoparticles and magnetic force10.1089/ten.2005.11.489 ↗
56. Restenosis: Repeat narrowing of a coronary artery—Prevention and treatment10.1161/01.CIR.0000019122.00032.DF ↗
57. The new face of bispecific antibodies: Targeting cancer and much more10.1016/j.exphem.2005.07.013 ↗
58. Tang, J., Shen, D., Zhang, J., Ligler, F.S., and Cheng, K. (2015). Bispecific antibodies, nanoparticles and cells: Bringing the right cells to get the job done. Expert Opin. Biol. Ther.10.1517/14712598.2015.1049944 ↗
59. Kean, T.J., Lin, P., Caplan, A.I., and Dennis, J.E. (2013). MSCs: Delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int.10.1155/2013/732742 ↗
60. Chemical generation of bispecific antibodies10.1073/pnas.1016478108 ↗
61. Electromagnetic Fields and Public Health. Available online: http://www.who.int/peh-emf/publications/facts/fs299/en/.